Dental Journal of Advance Studies

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  12 (2024)
Volume  11 (2023)
Volume  10 (2022)
Volume  9 (2021)
Volume  8 (2020)
Volume  7 (2019)
Volume  6 (2018)
Volume  5 (2017)
Volume  4 (2016)
Volume  3 (2015)
Volume  2 (2014)
Volume  1 (2013)
Related articles

VOLUME 4 , ISSUE 3 ( September-December, 2016 ) > List of Articles

Original Article

Clinical and Radiographic Evaluation of Mineral Trioxide Aggregate Pulpotomy in Permanent Teeth

Neha Verma, Avninder Kaur, Shivesh Acharya, Sunila Sharma

Keywords : Growth factors, pulp regeneration, Irreversible pulpitis, MTA Pulpotomy

Citation Information : Verma N, Kaur A, Acharya S, Sharma S. Clinical and Radiographic Evaluation of Mineral Trioxide Aggregate Pulpotomy in Permanent Teeth. 2016; 4 (3):183-188.

DOI: 10.1055/s-0038-1672067

License: NA

Published Online: 20-01-2017

Copyright Statement:  NA


Abstract

Aim and objective: The aim of the present study was to evaluate clinical and radiographic outcome of MTA as a pulpotomy agent in permanent teeth as an alternative to conventional root canal treatment. Materials and Methods: Ten permanent teeth with symptoms of irreversible pulpitis with vital pulp were selected for the study. MTAPulpotomy procedure was done in all the cases using standard protocol. Teeth were evaluated for various clinical and radiographic parameters at 3, 6, 9 and 12 months of follow up. Results: None of the patients reported any kind of clinical discomfort or radiographic abnormality during the follow up period of 3, 6, 9 and 12 months. All the teeth responded positive on electric pulp test at all successive follow ups. Conclusions: MTA Pulpotomy may be used as an alternative treatment modality to root canal treatment in permanent teeth with irreversible pulpitis, if future research continues to show promising results.

PDF Share
  1. Smith AJ. Vitality of the dentin-pulp complex in health and disease: growth factors as key mediators. J Dental Educ 2003; 67: 678–89.
  2. Hiremath H, Saikalyan S, Kulkarni SS & Hiremath V. Secondgeneration platelet concentrate (PRF) as a pulpotomy medicament in a permanent molar with pulpitis: a case report. Int Endod J 2012; 45: 105–12.
  3. Witherspoon DE, Small CJ, Harris ZG. Mineral trioxide aggregate pulpotomies. A case series outcomes assessment. J Am Dent Assoc 2006; 137:232-5.
  4. Godyl FG, Murray PE. Recommendations for using regenerative endodontic procedures in permanent immature traumatized teeth: invited review. Dent Traumatol 2012; 28:33-41.
  5. Murray PE, Garcia-Godoy F, Hargreaves KM. Regenerative endodontics. A review of current status and call for action. J Endod 2007; 33:377-90.
  6. Bakland LK. Endodontic consideration in dental trauma. In: Ingle JI, Bakland LK, eds. Endodontics. Toronto: BC Decker Inc: 2002:795-844.
  7. Fuks AB. Current concepts in vital primary pulp therapy. Eur J Paediatr Dent 2002;3:115-20.
  8. Asgary S, Eghbal MJ. A clinical trial of pulpotomy vs. root canal therapy of mature molars. J Dent Res 2010;89:1080–5.
  9. Wang Z, Pan J, Wright JT. Putative stem cells in human dental pulp with irreversible pulpitis: An Exploratory Study. J Endod 2010; 36:820-5.
  10. Hu CC, Zhang C, Qian Q, Tatum NB. Reparative dentin formation in rat molars after direct pulp capping with growth factors. J Endod 1998;24: 744–51.
  11. Sloan AJ, Smith AJ. Stimulation of the dentine-pulp complex of rat incisor teeth by transforming growth factor beta isoforms 1-3 in vitro. Arch Oral Biol 1999; 44: 149–56.
  12. Dentsply Endodontics. Materials safety data sheet (MSDS): ProRoot MTA (mineral trioxide aggregate) root canal repair material. Effective March 1, 2001.
  13. Caplan DJ, Cai J, Yin G, White BA. Root canal filled versus non-root canal filled teeth: a retrospective comparison of survival times. J Public Health Dent 2005;65: 90–6.
  14. McDougal RA, Delano EO, Caplan D, Sigurdsson A, Trope M. Success of an alternative for interim management of irreversible pulpitis. J Am Dent Assoc 2004; 135:1707–12.
  15. Eghbal MJ, Asgary S, Baglue RA, Parirokh M, Ghoddusi J. MTA pulpotomy of human permanent molars with irreversible pulpitis. Aust Endod J 2009; 35:4–8.
  16. Asgary S, Ehsani S. Permanent molar pulpotomy with a new endodontic cement: a case series. J Conserv Dent 2009; 12:31–6.
  17. Chacko V, Kurikose S. Human pulpal response to mineral trioxide aggregate (MTA): A histologic study. J Clin Pediatr Dent 2006;30: 203–9.
  18. Aeinehchi M, Eslami B, Ghanbariha M, Saffar AS. Mineral trioxide aggregate (MTA) and calcium hydroxide as pulpcapping agents in human teeth: a preliminary report. Int Endod J 2002; 36:225-31.
  19. Barngkgei IH, Halboub ES, Alboni RS. Pulpotomy of Symptomatic Permanent Teeth with Carious Exposure using Mineral Trioxide Aggerate. Iran Endod J 2013; 8(2):65-8.
  20. Schwarz R, Mauger M, Clement D, Walker W. Mineral trioxide aggregate: a new material for endodontics. J Am Dent Assoc 1999;130:967-75.
  21. Malekafzali B, Shekarchi F, Asgary S. Treatment outcomes of pulpotomy in primary molars using two endodontic biomaterials. A 2-year randomised clinical trial. Eur J Paediatr Dent 2011;12:189–93.
  22. Aguilar P, Linsuwanont P. Vital pulp therapy in vital permanent teeth with cariously exposed pulp: a systematic review. J Endod 2011; 37:581–7.
  23. Eghbal MJ, Asgary S, Baglue RA, Parirokh M, Ghoddusi J. MTA pulpotomy of human permanent molars with irreversible pulpitis. Aust Endod J 2009; 35:4–8.
  24. Dominguez RA, Munoz ML, Aznar MT. Study of calcium hydroxide apexification in 26 young permanent incisors. Dent Traumat 2005; 21:14-5.
  25. Anthonappa RP, King NM, Martens LC. Is there sufficient evidence to support the long term efficacy of mineral trioxide aggregate (MTA) for endodontic therapy in primary teeth? Int Endod J 2013; 46:198-204.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.